Prevalence of Hyperhomocysteinemia in Hemodialysis Patients in the United Arab Emirates,a One Center Experience,Correlation with Diabetes Mellitus,Folate,and Dialysis Modality
Open accessResearch articleFirst published online 2011
Prevalence of Hyperhomocysteinemia in Hemodialysis Patients in the United Arab Emirates,a One Center Experience,Correlation with Diabetes Mellitus,Folate,and Dialysis Modality
Hyperhomocysteinemia is a non-traditional independent risk factor for cardiovascular disease. It is highly prevalent in Western dialysis patients, while its prevalence in the Middle East is unknown. The aim of this study is to determine the prevalence of hyperhomocys-teinemia among our hemodialysis (HD) patients, and to identify correlations between homocysteine and diabetes mellitus (DM), folic acid, and dialysis modality. Homocysteine and folate levels were measured in 83 stable HD patients: 52 males, mean age 56.4±17.6 years, 58% were diabetic, 61% were treated by traditional HD, and 39% treated by online hemodiafiltration (HDF). Of the studied patients, 99% have abnormal homocysteine with a mean level of 27±10.8 mmol/L. The homocysteine level in diabetics and non-diabetics was 28.7±11.3 and 25.5±9.7, respectively (P=0.17); the level in HDF and HD patients was 29.7±10.5 and 25.8±10.5, respectively (P=0.1). In summary, hyperhomocysteinemia is highly prevalent in our HD population.
PaulF.J., AndrewG.B., PeterW.F.Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.Am J Clin Nutr2001; 73: 613–21.
2.
AllonN.F., AndrewG.B., JacobS.The Kidney and Homocysteine Metabolism.J Am Soc Nephrol2001; 12: 2181–9.
3.
BeatrizB., MariC., JordiB.Homocysteine and lipid peroxidation in haemodialysis: role of folinic acid and vitamin E.Nephrol Dial Transplant2001; 16: 2172–5.
4.
AnavekarN.S., McMurrayJ.J., VelazquezE.J.Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.N Engl J Med2004; 351: 1285–95.
5.
PinkauT., HilgersK.F., VeelkenR., MannJ.F.E.How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease?J Am Soc Nephrol2004; 15: 517–23.
6.
WelchG.N., LoscalzoJ.N.Homocysteine and Atherothrombosis.Engl J Med1998; 15: 1042–50.
7.
BilginO., DilekO., NevbaharT.Association Between Homocysteinemia and Renal Function in Patients with Type 2 Diabetes Mellitus.Ann Clin Lab Sci2002; 32: 279–86.
8.
TamuraT., JohnstonK.E., and BergmanS.M.Homocysteine and folate concentrations in blood from patients treated with hemodialysis.JASN1996; 7: 2414–8.
9.
DavidW.M., RobynR., PeterH.Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.Neph Dial Trans2005; 20: 2178–85.
10.
VivianF., SusanC.G., and LouisM.F.Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis.Endoc Rev2000; 20: 738.
11.
VanG.C., RobinsonK.Homocysteine and renal disease.Semin Thromb Hemost2000; 26: 313–24.
12.
Van GuldenerC., RobinsonK.Homocysteine and renal disease.Semin Thromb Hemost2000; 26: 313–24.
13.
SchwabU., TorronenA., MeririnneE.Orally administered betaine has an acute and dose-dependent effect on serum betaine and plasma homocysteine concentrations in healthy humans.J Nutr2005; 136: 34–8.
14.
KatsushiK., TakeshiU., OkiT.Efficacy of methylcobalamin on lowering total] homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation.Nephrol Dial Trans2002; 17: 916–22.
15.
WollesenF., BrattstromL., RefsumH.Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.Kidney Int1999; 55: 1028–35.
16.
VeldmanB.A., VervoortG., BlomH., SmitsP.Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance.Diabet Med2005; 22: 301–5.
17.
NorlundL., GrubbA., FexG.The increase of plasma homocysteine with age is partly due to the deterioration of renal function as determined by plasma cystatin C.Clin Chem Lab Med1998; 36: 175–8.
18.
HultbergB., AnderssonA., SternerG.Plasma homocysteine in renal failure.Clin Nephrol1993; 40: 230–5.
19.
GuentherB.D., SheppardC.A., TranP.The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia.Nat Struct Biol1999; 6: 359–65.
20.
Stolzenberg-SolomonR.Z., MillerER3rd, MaguireM.G.Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population.Am J Clin Nutr1999; 69: 467–75.
21.
Van der GaagM., UbbinkJ.B., SillanaukeeP.Effect of consumption of red wine, spirits, and beer on serum homocysteine.Lancet2000; 355: 1522.
22.
LivantE.J., TamuraT., JohnstonK.E.Plasma folate conjugase activities and folate concentrations in patients receiving hemo-dialysis.J Nutr Biochem1994; 5: 504–8.
23.
Van TellingenA., GrootemanM.P., BartelsP.C.Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients.Kidney Int.2001. 59: 342–34710.
24.
GalliF., BenedettiS., BuoncristianiU.The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels.Kidney Int2003; 64: 748–55.
25.
De VrieseA.S., LangloisM., BernardD.Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients.Nephrol Dial Trans2003; 18
26.
ArakiA., SakoY., ItoH.Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment.Atherosclerosis1993; 103: 149–57.
27.
SoinioM., MarniemiJ., LaaksoM.Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type 2 Diabetes MellitusAnn Intern Med2004; 140: 94–100.
28.
BeckerA., KostenseP.J., BosG.Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes.J Intern Med2003; 253: 293–300.
29.
BrattstromL., IsraelssonB., NorrvingB.Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment.Atherosclerosis1990; 81: 51–60.
